1. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells;Abrams;J Exp Med,2000
2. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 Therapy: A new therapeutic approach;Asadullah;J Clin Invest,1998
3. PUVA therapy decreases HLA-DR+ CDia+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDia+ Langerhans cells exhibit normal alloantigen-presenting function;Ashworth;Br J Dermatol,1989
4. Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis;Austin;J Cutan Pathol,1998
5. Intracellular TNF-alpha, IFN-gamma, and IL-2 identify TC1 and TH1 effector populations in psoriasis vulgaris plaque lymphocytes: Single-cell analysis by flow cytometry;Austin;J Invest Dermatol,1998